Materias dentro de su búsqueda.
Materias dentro de su búsqueda.
Historia
27
Filosofía
14
Libre albedrío y determinismo
10
Jazz
9
Música popular
9
Aspectos económicos
8
Sociología
8
Etnología
7
Comercio
6
Aspectos psicológicos
5
Aspectos sociales
5
Cambio social
5
Ciudades y pueblos
5
Libre comercio
5
Modelos matemáticos
5
Política económica
5
Política gubernamental
5
Abuso de drogas
4
Administración
4
Ciencias sociales
4
Condiciones sociales
4
Democracia
4
Educación
4
Filosofía de la mente
4
History
4
Inglés
4
Mercadotecnia
4
Política y gobierno
4
Sistemas operativos (Computadoras)
4
Urbanismo
4
-
485701por Wilkinson, Vicky, Takano, Kotaro, Nichols, David, Martin, Alynn, Holme, Roz, Phalen, David, Mounsey, Kate, Charleston, Michael, Kreiss, Alexandre, Pye, Ruth, Browne, Elizabeth, Næsborg-Nielsen, Christina, Richards, Shane A., Carver, Scott“…Clinical resolution of sarcoptic mange was observed in all study animals within 3–4 weeks of treatment, and all wombats remained tick-free for 15 weeks. A suitable product for diluting fluralaner into a ‘pour-on’ was found. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
485702por Cruz, Cecilia Beatriz Bittencourt Viana, Hajjar, Ludhmila A., Bacal, Fernando, Lofrano-Alves, Marco S., Lima, Márcio S. M., Abduch, Maria C., Viera, Marcelo L. C., Chiang, Hsu P., Salviano, Juliana B. C., da Silva Costa, Isabela Bispo Santos, Fukushima, Julia Tizue, Sbano, Joao C. N., Mathias, Wilson, Tsutsui, Jeane M.“…Conventional echocardiographic parameters, left ventricular global longitudinal, radial and circumferential strain (LV-GLS, LV-GRS and LV-GCS, respectively), left ventricular systolic twist (LV-twist) and right ventricular free wall longitudinal strain (RV-FWLS) were analyzed just before the procedure. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
485703por Lalos, Alexandros, Tülek, Ali, Tosti, Nadia, Mechera, Robert, Wilhelm, Alexander, Soysal, Savas, Daester, Silvio, Kancherla, Venkatesh, Weixler, Benjamin, Spagnoli, Giulio C., Eppenberger-Castori, Serenella, Terracciano, Luigi, Piscuoglio, Salvatore, von Flüe, Markus, Posabella, Alberto, Droeser, Raoul A.“…A variety of studies have shown that high densities of infiltrating CD8+ T-cells are associated with improved disease-free and overall survival in CRC. Stromal cell-derived factor-1 (SDF-1) is a protein that regulates leukocyte trafficking and is variably expressed in several healthy and malignant tissues. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
485704por Desai, Amit, Benner, Lauren, Wu, Ruishan, Gertsik, Lev, Uz, Tolga, Marek, Gerard J., Zhu, Tong“…Furthermore, the concentration of ASP4345 in cerebrospinal fluid compared to free drug concentrations in plasma provides evidence of penetration of ASP4345 into the brain.…”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
485705por Sutton, Elizabeth J., Braunstein, Lior Z., El-Tamer, Mahmoud B., Brogi, Edi, Hughes, Mary, Bryce, Yolanda, Gluskin, Jill S., Powell, Simon, Woosley, Alyssa, Tadros, Audree, Sevilimedu, Varadan, Martinez, Danny F., Toni, Larowin, Smelianskaia, Olga, Nyman, C. Gregory, Razavi, Pedram, Norton, Larry, Fung, Maggie M., Sedorovich, James D., Sacchini, Virgilio, Morris, Elizabeth A.“…IMPORTANCE: After neoadjuvant chemotherapy (NAC), pathologic complete response (pCR) is an optimal outcome and a surrogate end point for improved disease-free and overall survival. To date, surgical resection remains the only reliable method for diagnosing pCR. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
485706por Schmid, Peter, Sablin, Marie-Paule, Bergh, Jonas, Im, Seock-Ah, Lu, Yen-Shen, Martínez, Noelia, Neven, Patrick, Lee, Keun Seok, Morales, Serafín, Pérez-Fidalgo, J. Alejandro, Adamson, Douglas, Gonçalves, Anthony, Prat, Aleix, Jerusalem, Guy, Schlieker, Laura, Espadero, Rosa-Maria, Bogenrieder, Thomas, Huang, Dennis Chin-Lun, Crown, John, Cortés, Javier“…Primary endpoint was progression-free survival (PFS). RESULTS: MTD was determined as xentuzumab 1000 mg weekly plus everolimus 10 mg/day and exemestane 25 mg/day. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
485707por Young, Graeme P., Symonds, Erin L., Nielsen, Hans Jørgen, Ferm, Linnea, Christensen, Ib J., Dekker, Evelien, van der Vlugt, Manon, Mallant-Hent, Rosalie C., Boulter, Nicky, Yu, Betty, Chan, Michelle, Tevz, Gregor, LaPointe, Lawrence C., Pedersen, Susanne K.“…This study aimed to evaluate the clinical utility of assaying circulating cell-free DNA for methylation in BCAT1, IKZF1 and IRF4 for detection of CRC. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
485708por Mpofu, Rephaim, Otwombe, Kennedy, Mlisana, Koleka, Nchabeleng, Maphoshane, Allen, Mary, Kublin, James, McElrath, M. Juliana, Bekker, Linda-Gail, Churchyard, Gavin, Gray, Glenda, Laher, FatimaEnlace del recurso
Publicado 2021
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
485709por Rugo, Hope S., Im, Seock-Ah, Cardoso, Fatima, Cortés, Javier, Curigliano, Giuseppe, Musolino, Antonino, Pegram, Mark D., Wright, Gail S., Saura, Cristina, Escrivá-de-Romaní, Santiago, De Laurentiis, Michelino, Levy, Christelle, Brown-Glaberman, Ursa, Ferrero, Jean-Marc, de Boer, Maaike, Kim, Sung-Bae, Petráková, Katarína, Yardley, Denise A., Freedman, Orit, Jakobsen, Erik H., Kaufman, Bella, Yerushalmi, Rinat, Fasching, Peter A., Nordstrom, Jeffrey L., Bonvini, Ezio, Koenig, Scott, Edlich, Sutton, Hong, Shengyan, Rock, Edwin P., Gradishar, William J.“…MAIN OUTCOMES AND MEASURES: Sequential primary end points were progression-free survival (PFS) by central blinded analysis and overall survival (OS). …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
485710por Politch, Joseph A., Cu-Uvin, Susan, Moench, Thomas R., Tashima, Karen T., Marathe, Jai G., Guthrie, Kate M., Cabral, Howard, Nyhuis, Tara, Brennan, Miles, Zeitlin, Larry, Spiegel, Hans M. L., Mayer, Kenneth H., Whaley, Kevin J., Anderson, Deborah J.Enlace del recurso
Publicado 2021
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
485711por Pierce, Stuart R., Fang, Ziwei, Yin, Yajie, West, Lindsay, Asher, Majdouline, Hao, Tianran, Zhang, Xin, Tucker, Katherine, Staley, Allison, Fan, Yali, Sun, Wenchuan, Moore, Dominic T., Xu, Chang, Tsai, Yi-Hsuan, Parker, Joel, Prabhu, Varun Vijay, Allen, Joshua E., Lee, Douglas, Zhou, Chunxiao, Bae-Jump, Victoria“…RESULTS: Increasing DRD2 expression in endometrial cancer was significantly associated with grade, serous histology and stage, as well as worse progression free survival and overall survival. Higher expression of DRD2 mRNA was found for the Copy Number High (CNH) subtype when compared to the other subtypes. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
485712por Thorson, A. E., Deen, G. F., Bernstein, K. T., Liu, W. J., Yamba, F., Habib, N., Sesay, F. R., Gaillard, P., Massaquoi, T. A., McDonald, S. L. R., Zhang, Y., Durski, K. N., Singaravelu, S., Ervin, E., Liu, H., Coursier, A., Marrinan, J. E., Ariyarajah, A., Carino, M., Formenty, P., Ströher, U., Lamunu, M., Wu, G., Sahr, F., Xu, W., Knust, B., Broutet, N.Enlace del recurso
Publicado 2021
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
485713por Stankowska, Dorota L., Millar, J. Cameron, Kodati, Bindu, Behera, Sumita, Chaphalkar, Renuka M., Nguyen, Tam, Nguyen, Kytai T., Krishnamoorthy, Raghu R., Ellis, Dorette Z., Acharya, Suchismita“…Additionally, the PLGA nanosuspension formulation (SA-2 NPs) provided longer duration of IOP-lowering activity (up to 3 days) in comparison with the free non-encapsulated SA-2 drug. The data have implications for developing novel, non-prostaglandin therapeutics for IOP-lowering and cytoprotective effects with the possibility of an eye drop dosing regimen of once every 3 days for patients with glaucoma.…”
Publicado 2021
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
485714por Grenda, Anna, Krawczyk, Paweł, Błach, Justyna, Chmielewska, Izabela, Kubiatowski, Tomasz, Kieszko, Stanisław, Wojas-Krawczyk, Kamila, Kucharczyk, Tomasz, Jarosz, Bożena, Paśnik, Iwona, Borowiec-Bar, Małgorzata, Frąk, Małgorzata, Kieszko, Robert, Szczyrek, Michał, Reszka, Katarzyna, Krukowska, Kinga, Kolak, Agnieszka, Mańdziuk, Sławomir, Kowalski, Dariusz, Sawicki, Marek, Świniuch, Daria, Starosławska, Elżbieta, Ramlau, Rodryg, Szumiło, Justyna, Krzakowski, Maciej, Milanowski, Janusz“…The response rate to immunotherapy and progression free survival (PFS) measured in weeks and overall survival (OS) measured in months from the start of immunotherapy were evaluated. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
485715por Cortellini, Alessio, De Giglio, Andrea, Cannita, Katia, Cortinovis, Diego L., Cornelissen, Robin, Baldessari, Cinzia, Giusti, Raffaele, D'Argento, Ettore, Grossi, Francesco, Santoni, Matteo, Catino, Annamaria, Berardi, Rossana, Sforza, Vincenzo, Rossi, Giovanni, Antonuzzo, Lorenzo, Di Noia, Vincenzo, Signorelli, Diego, Gelibter, Alain, Occhipinti, Mario Alberto, Follador, Alessandro, Rastelli, Francesca, Chiari, Rita, Gravara, Luigi Della, Inno, Alessandro, De Tursi, Michele, Di Marino, Pietro, Mansueto, Giovanni, Zoratto, Federica, Filetti, Marco, Montrone, Michele, Citarella, Fabrizio, Pensieri, Maria Vittoria, Russano, Marco, Cantini, Luca, Nigro, Olga, Leonetti, Alessandro, Bordi, Paola, Minuti, Gabriele, Landi, Lorenza, De Toma, Alessandro, Donisi, Clelia, Ricciardi, Serena, Migliorino, Maria Rita, Napoli, Valerio Maria, Leone, Gianmarco, Metro, Giulio, Banna, Giuseppe L., Friedlaender, Alex, Addeo, Alfredo, Ficorella, Corrado, Porzio, Giampiero“…Within the matched pembrolizumab cohort, never smokers had a significantly shorter progression‐free survival (PFS) (HR = 1.68 [95% CI: 1.17–2.40], p = 0.0045) and a nonsignificant trend towards a shortened overall survival (OS) (HR = 1.32 [95% CI: 0.84–2.07], p = 0.2205). …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
485716por Lafond, Kathryn E., Porter, Rachael M., Whaley, Melissa J., Suizan, Zhou, Ran, Zhang, Aleem, Mohammad Abdul, Thapa, Binay, Sar, Borann, Proschle, Viviana Sotomayor, Peng, Zhibin, Feng, Luzhao, Coulibaly, Daouda, Nkwembe, Edith, Olmedo, Alfredo, Ampofo, William, Saha, Siddhartha, Chadha, Mandeep, Mangiri, Amalya, Setiawaty, Vivi, Ali, Sami Sheikh, Chaves, Sandra S., Otorbaeva, Dinagul, Keosavanh, Onechanh, Saleh, Majd, Ho, Antonia, Alexander, Burmaa, Oumzil, Hicham, Baral, Kedar Prasad, Huang, Q. Sue, Adebayo, Adedeji A., Al-Abaidani, Idris, von Horoch, Marta, Cohen, Cheryl, Tempia, Stefano, Mmbaga, Vida, Chittaganpitch, Malinee, Casal, Mariana, Dang, Duc Anh, Couto, Paula, Nair, Harish, Bresee, Joseph S., Olsen, Sonja J., Azziz-Baumgartner, Eduardo, Nuorti, J. Pekka, Widdowson, Marc-AlainEnlace del recurso
Publicado 2021
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
485717por Wang, Hao, Tang, Han, Fang, Yong, Tan, Lijie, Yin, Jun, Shen, Yaxing, Zeng, Zhaochong, Zhu, Jiangyi, Hou, Yingyong, Du, Ming, Jiao, Jia, Jiang, Hongjing, Gong, Lei, Li, Zhigang, Liu, Jun, Xie, Deyao, Li, Wenfeng, Lian, Changhong, Zhao, Qiang, Chen, Chun, Zheng, Bin, Liao, Yongde, Li, Kuo, Li, Hecheng, Wu, Han, Dai, Liang, Chen, Ke-Neng“…Secondary outcomes included postoperative complications, mortality, postoperative pathologic outcome, recurrence-free survival time, and quality of life. RESULTS: Among 264 patients (226 men [85.6%]; mean [SD] age, 61.4 [6.8] years), postoperative morbidity was 47.4% in the nCRT group (54 of 114) and 42.6% in the nCT group (46 of 108), with no significant difference between groups (difference, 4.8%; 95% CI, −8.2% to 17.5%; P = .48). …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
485718por Del Fiore, Paolo, Rastrelli, Marco, Dall’Olmo, Luigi, Cavallin, Francesco, Cappellesso, Rocco, Vecchiato, Antonella, Buja, Alessandra, Spina, Romina, Parisi, Alessandro, Mazzarotto, Renzo, Ferrazzi, Beatrice, Grego, Andrea, Rotondi, Alessio, Benna, Clara, Tropea, Saveria, Russano, Francesco, Filoni, Angela, Bassetto, Franco, Dei Tos, Angelo Paolo, Alaibac, Mauro, Rossi, Carlo Riccardo, Pigozzo, Jacopo, Sileni, Vanna Chiarion, Mocellin, Simone“…RESULTS: Median follow-up was 32 months (IQR: 15–84). 3-year progression-free survival (PFS) was 54%, while 3-year overall survival (OS) was 62%. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
485719por Zienius, Dainius, Mickutė, Janina, Pautienius, Arnoldas, Grigas, Juozas, Stankevičius, Arunas, Pridotkas, Gediminas, Jacevičius, Eugenijus, Kemeraitė, Jolita, Jacevičienė, Ingrida“…CONCLUSIONS: The 2010–2019 ORV programme has been an effective tool in both RF and RD populations in Lithuania. The rabies-free status of Lithuania was self-declared in 2015 with only three rabies cases identified in buffer zones since then. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
485720por Janssen, Q. P., van Dam, J. L., Bonsing, B. A., Bos, H., Bosscha, K. P., Coene, P. P. L. O., van Eijck, C. H. J., de Hingh, I. H. J. T., Karsten, T. M., van der Kolk, M. B., Patijn, G. A., Liem, M. S. L., van Santvoort, H. C., Loosveld, O. J. L., de Vos-Geelen, J., Zonderhuis, B. M., Homs, M. Y. V., van Tienhoven, G., Besselink, M. G., Wilmink, J. W., Groot Koerkamp, B.“…Secondary endpoints include progression-free survival, quality of life, resection rate, and R0 resection rate. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto